DELL TECHNOLOGIES -C
DELLNYSE🏆 #45 by market capEarnings Nov 23US Equity
$493.71▼ $8.23 (−1.64%)
🌙 After hours$484.05▼ 1.96%Regular close · extended-hours price shownTrack DELL
Get earnings, price moves & breaking news on Telegram
24h▼ 1.6%
7d▲ 1.4%
14d▼ 2.7%
30d▼ 9.2%
ytd▲ 292.2%
1y▲ 199.4%
🏦Market Cap
$313.91B
Large Cap
📈Revenue Growth (YoY)
49.0%
High Growth
📊Gross Margin
19.8%
Thin
💵FCF Margin
5.7%
Moderate
⚖️P/S Ratio
2.0x
Cheap
Otter Score
68
Fair
DELL TECHNOLOGIES -C
DELLAnalyst Ratings
Price
$493.71
Total
45
Raised
4
Lowered
10
Avg PT
$564.65
H / L
$735 / $289
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Barclays | Downgraded | Overweight → Equal Weight | 2026-10-14 | $574.00 | +16.30% |
Mizuho | Reiterated | Outperform | 2026-10-06 | — | — |
TD Cowen | Reiterated | Hold | 2026-09-29 | — | — |
Morgan Stanley | Reiterated | Equal Weight | 2026-09-21 | $511.00 | +3.50% |
Evercore ISI Group | Reiterated | Outperform | 2026-09-09 | — | — |
Melius Research | Reiterated | Buy | 2026-09-02 | $735.00 | +48.90% |
Goldman Sachs | Reiterated | Buy | 2026-09-02 | $570.00 | +15.50% |
Piper Sandler | Reiterated | Overweight | 2026-09-02 | $558.00 | +13.00% |
Truist Securities | Reiterated | Hold | 2026-09-02 | — | — |
Raymond James | Reiterated | Outperform | 2026-09-02 | $617.00 | +25.00% |
Citigroup | Reiterated | Buy | 2026-09-02 | $155.00 | −68.60% |
B of A Securities | Reiterated | Buy | 2026-09-02 | — | — |
JP Morgan | Reiterated | Overweight | 2026-09-02 | — | — |
UBS | Reiterated | Neutral | 2026-09-02 | $500.00 | +1.30% |
Bernstein | Reiterated | Outperform | 2026-09-02 | $650.00 | +31.70% |
Deutsche Bank | Downgraded | Buy → Hold | 2026-09-01 | $520.00 | +5.30% |
Wells Fargo | Reiterated | Overweight | 2026-08-14 | $545.00 | +10.40% |
Argus Research | Reiterated | Buy | 2026-05-29 | $460.00 | −6.80% |
Susquehanna | Upgraded | Neutral → Positive | 2026-05-29 | $289.00 | −41.50% |
Loop Capital | Reiterated | Buy | 2026-05-29 | — | — |
Daiwa Capital | Upgraded | Neutral → Outperform | 2023-09-19 | — | — |
Credit Suisse | Reiterated | Outperform | 2023-06-02 | $53.00 | −89.30% |
Jefferies | Reiterated | Hold | 2022-10-31 | — | — |
Cowen & Co. | Reiterated | Market Perform | 2022-08-26 | — | — |
OTR Global | Upgraded | Mixed → Positive | 2021-08-05 | — | — |
RBC Capital | Upgraded | Sector Perform → Outperform | 2020-08-28 | $640.00 | +29.60% |
Nomura | Reiterated | Neutral | 2020-05-29 | — | — |
Nomura Instinet | Reiterated | Neutral | 2020-05-29 | — | — |
BMO Capital | Reiterated | Market Perform | 2019-03-04 | — | — |
Wolfe Research | Reiterated | Outperform | 2019-01-09 | — | — |
Gabelli & Co. | Reiterated | Buy | 2018-01-31 | — | — |
Topeka | Reiterated | Buy | 2013-03-07 | — | — |
FBN Securities | Reiterated | Sector Perform | 2013-02-20 | — | — |
Brean Capital | Downgraded | Buy → Hold | 2013-02-14 | — | — |
Maxim Group | Downgraded | Buy → Hold | 2013-02-13 | — | — |
Credit Agricole | Downgraded | Outperform → Underperform | 2013-02-06 | — | — |
Cross Research | Downgraded | Buy → Hold | 2013-02-05 | — | — |
Stifel Nicolaus | Downgraded | Buy → Hold | 2013-02-05 | — | — |
Argus Capital | Downgraded | Buy → Hold | 2013-01-16 | — | — |
Monness, Crespi, Hardt | Downgraded | Buy → Neutral | 2013-01-15 | — | — |
Monness Crespi Hardt | Reiterated | Buy | 2012-09-10 | — | — |
Edward Jones | Downgraded | Hold → Sell | 2012-09-07 | — | — |
Bank of America | Reiterated | Buy | 2012-08-22 | — | — |
Sterne Agee | Reiterated | Neutral | 2012-05-17 | — | — |
Oxen Group | Reiterated | Buy | 2012-03-14 | — | — |
Institution
Barclays
Downgraded · Overweight → Equal Weight · 2026-10-14
$574.00
+16.30%
Mizuho
Reiterated · Outperform · 2026-10-06
—
—
TD Cowen
Reiterated · Hold · 2026-09-29
—
—
Morgan Stanley
Reiterated · Equal Weight · 2026-09-21
$511.00
+3.50%
Evercore ISI Group
Reiterated · Outperform · 2026-09-09
—
—
Melius Research
Reiterated · Buy · 2026-09-02
$735.00
+48.90%
Goldman Sachs
Reiterated · Buy · 2026-09-02
$570.00
+15.50%
Piper Sandler
Reiterated · Overweight · 2026-09-02
$558.00
+13.00%
Truist Securities
Reiterated · Hold · 2026-09-02
—
—
Raymond James
Reiterated · Outperform · 2026-09-02
$617.00
+25.00%
Citigroup
Reiterated · Buy · 2026-09-02
$155.00
−68.60%
B of A Securities
Reiterated · Buy · 2026-09-02
—
—
JP Morgan
Reiterated · Overweight · 2026-09-02
—
—
UBS
Reiterated · Neutral · 2026-09-02
$500.00
+1.30%
Bernstein
Reiterated · Outperform · 2026-09-02
$650.00
+31.70%
Deutsche Bank
Downgraded · Buy → Hold · 2026-09-01
$520.00
+5.30%
Wells Fargo
Reiterated · Overweight · 2026-08-14
$545.00
+10.40%
Argus Research
Reiterated · Buy · 2026-05-29
$460.00
−6.80%
Susquehanna
Upgraded · Neutral → Positive · 2026-05-29
$289.00
−41.50%
Loop Capital
Reiterated · Buy · 2026-05-29
—
—
Daiwa Capital
Upgraded · Neutral → Outperform · 2023-09-19
—
—
Credit Suisse
Reiterated · Outperform · 2023-06-02
$53.00
−89.30%
Jefferies
Reiterated · Hold · 2022-10-31
—
—
Cowen & Co.
Reiterated · Market Perform · 2022-08-26
—
—
OTR Global
Upgraded · Mixed → Positive · 2021-08-05
—
—
RBC Capital
Upgraded · Sector Perform → Outperform · 2020-08-28
$640.00
+29.60%
Nomura
Reiterated · Neutral · 2020-05-29
—
—
Nomura Instinet
Reiterated · Neutral · 2020-05-29
—
—
BMO Capital
Reiterated · Market Perform · 2019-03-04
—
—
Wolfe Research
Reiterated · Outperform · 2019-01-09
—
—
Gabelli & Co.
Reiterated · Buy · 2018-01-31
—
—
Topeka
Reiterated · Buy · 2013-03-07
—
—
FBN Securities
Reiterated · Sector Perform · 2013-02-20
—
—
Brean Capital
Downgraded · Buy → Hold · 2013-02-14
—
—
Maxim Group
Downgraded · Buy → Hold · 2013-02-13
—
—
Credit Agricole
Downgraded · Outperform → Underperform · 2013-02-06
—
—
Cross Research
Downgraded · Buy → Hold · 2013-02-05
—
—
Stifel Nicolaus
Downgraded · Buy → Hold · 2013-02-05
—
—
Argus Capital
Downgraded · Buy → Hold · 2013-01-16
—
—
Monness, Crespi, Hardt
Downgraded · Buy → Neutral · 2013-01-15
—
—
Monness Crespi Hardt
Reiterated · Buy · 2012-09-10
—
—
Edward Jones
Downgraded · Hold → Sell · 2012-09-07
—
—
Bank of America
Reiterated · Buy · 2012-08-22
—
—
Sterne Agee
Reiterated · Neutral · 2012-05-17
—
—
Oxen Group
Reiterated · Buy · 2012-03-14
—
—
One row per institution · price target from the firm's latest published target